Not permanently, but consistently eating glutathione-rich foods can help brighten skin and reduce pigmentation over time
More recently, encouraging clinical results from a triple-hormone-receptor agonist, Retatrutide, and several GLP-1R/GCGR dual agonists, suggest that GCGR could be a promising co-stimulating target for type 2 diabetes and obesity
Allowing for small, incremental dose adjustments may improve tolerability and optimize long-term treatment outcomes
The April 9, 2026, Health Canada public advisory reinforced the warning, naming BPC-157 alongside roughly 40 other peptides flagged for unauthorized sale
The findings, which have not yet been peer-reviewed, were presented at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans earlier this month